Are you prepared to recognize and treat anxiety, depression, and other comorbid psychiatric disorders when they arise in your patients?
This study points to nitrated nucleosomes as a promising biomarker for distinguishing neuropsychiatric events due to systemic lupus erythematosus from those secondary to other disorders.
Among the highlights of 3 recent studies: insights into hormonal risk factors for rheumatoid arthritis.
An online tool for juvenile arthritis, guidelines on childhood lupus, and good news about the response to treatment for ANCA-associated vasculitis
Highlights of 5 topline news stories from the FDA, CDC, and American College of Rheumatology—with real-world implications for primary care practice.
Be vigilant for the development of type 2 diabetes in patients with systemic lupus erythematosus.
Among the culprits: sunlight, cigarettes, and oral contraceptives.
What underlies the disparity in life expectancy between men and women with SLE?
The goal: to find a treatment target that protects against damage accrual in the early stages of SLE.
In patients with SLE, increased intake of omega-3 fatty acids led to better sleep and fewer symptoms of depression.